Tumor biopsies collected at baseline were denoted as B-ICC, while those treated with ICBs (PD-1 or PD-L1/CTLA-4) were marked as T-ICC (Fig. 7A). This evidence concerns the gene CD274 and intrahepatic cholangiocarcinoma.